Caprihans India Limited (BOM:509486)

India flag India · Delayed Price · Currency is INR
74.00
+4.88 (7.06%)
At close: May 26, 2026
Market Cap1.16B -35.4%
Revenue (ttm)7.43B +0.5%
Net Income-470.00M
EPS-32.08
Shares Out 15.91M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume3,967
Open72.01
Previous Close69.12
Day's Range72.00 - 75.99
52-Week Range50.30 - 167.70
Beta0.73
Analystsn/a
Price Targetn/a
Earnings DateMay 25, 2026

About Caprihans India

Caprihans India Limited engages in the pharmaceutical packaging business in India and internationally. The company also manufactures and sells rigid and flexible polyvinyl chloride (PVC) films, polyvinylidene chloride (PVDC) coated films, plastic extruded products, alu alu foils, and other allied products. In addition, it provides thermoforming blister films under the Duplex, Triplex, Ultra, Ultra Tx, Armour, Aclar, Excel, Exxtra, Optra, BAPP, Zymax, Zymax Tx, and Zymax PDP names; coldforming blister foils under the Venus, Venus PR, Venus SBC, ... [Read more]

Industry Miscellaneous Plastics Products
Founded 1946
Employees 540
Stock Exchange Bombay Stock Exchange
Ticker Symbol 509486
Full Company Profile

Financial Performance

In fiscal year 2026, Caprihans India's revenue was 7.43 billion, an increase of 0.45% compared to the previous year's 7.40 billion. Losses were -470.00 million, -24.41% less than in 2025.

Financial Statements